Skip to main content

Medical Billing & Credentialing Services | Prohealthcare Advisors

Oncology Billing Credentialing Services

Securing Revenue Integrity for High-Complexity Cancer Care

Oncology billing carries some of the highest financial stakes in medicine — chemotherapy administration codes (96401–96549), biosimilar substitution rules, and prior authorization for high-cost specialty drugs each require precise, payer-specific handling. A single denied prior auth on a six-figure treatment plan can devastate a practice's cash flow. We track these details so oncology practices don't absorb that risk.

We manage license renewal tracking, monthly OIG/SAM exclusion checks, and enrollment across the payers and specialty pharmacy networks most active in oncology — so your team can focus on cancer care while we protect every claim, from chemotherapy administration to radiation therapy bundling.

Oncology Billing
Oncology billing credentialing services
98.5%Clean Claim Rate
Under 2%Denial Rate
15+Years of Experience
15Specialties We Support

Oncology Billing Complexity Areas

Where Oncology Claims Most Often Go Wrong

Billing AreaCommon RiskHow We Manage It
Chemo Administration (96401–96549)Incorrect sequencing when multiple drugs are administered same-sessionSession-level coding review before submission
Biosimilar SubstitutionPayer-specific rules on originator vs. biosimilar billingPayer-by-payer biosimilar policy tracking
High-Cost Drug Prior AuthDenials on six-figure treatment plansPre-treatment authorization verification
ICD-10 Staging SpecificityDenials from insufficient staging detailDocumentation review against payer specificity requirements
Radiation Therapy BundlingNCCI edits on same-course treatment codesModifier verification before claim submission

Chemotherapy Billing Codes

The Codes Behind Every Oncology Claim

Oncology claims are paid on a small set of elements — chemotherapy administration codes, biosimilar substitution rules, prior authorization for high-cost specialty drugs, staging specificity, and radiation therapy bundling. We check each one before a claim is submitted:

Code(s)ServiceWhat We Check
96401–96549Chemotherapy administrationSession-level coding review before submission — we check sequencing when multiple drugs are administered in the same session, the most common cause of denials under these codes.

Billing elements we check on every oncology claim

  • Biosimilar substitution — payer-by-payer biosimilar policy tracking, so the originator or biosimilar billed matches each payer's rules.
  • High-cost drug prior authorization — verified before treatment begins and monitored throughout the full treatment course, including mid-treatment re-verification.
  • ICD-10 staging specificity — documentation reviewed against each payer's specificity requirements before submission.
  • Radiation therapy bundling — modifier verification before claim submission, with NCCI edits on same-course treatment codes checked.

Payer Enrollment & Compliance

Keeping Oncology Practices Enrolled and Compliant

Strategic Payer Integration for Oncology Practices

We manage license renewal tracking, monthly OIG/SAM exclusion checks, and enrollment across the payers and specialty pharmacy networks most active in oncology. Because high-cost drug authorizations often require re-verification mid-treatment, we monitor authorization status throughout a patient's full treatment course, not just at intake.

Staying enrolled keeps your practice paid: license renewal tracking and monthly OIG/SAM exclusion checks keep your credentials current, and enrollment across the payers and specialty pharmacy networks most active in oncology means authorizations and claims are not interrupted by a lapsed renewal or an enrollment gap.

Payers we enroll with include:

Medicare Medicaid Aetna Blue Cross Blue Shield UnitedHealthcare Cigna

Sharpening Coding Precision for High-Cost Cancer Care

Chemotherapy administration is where oncology claims most often go wrong. When multiple drugs are administered in the same session, incorrect sequencing under codes 96401–96549 is the most common cause of denials — and a single denied prior authorization on a six-figure treatment plan can devastate a practice's cash flow. We review session-level coding before submission, so sequencing errors are caught before they reach the payer, not after a denial.

  • Session-level coding review — checked before submission, so multiple-drug sessions are sequenced correctly.
  • Biosimilar policy tracking — payer-specific rules on originator versus biosimilar billing, tracked payer by payer.
  • Modifier verification — NCCI edits on same-course radiation treatment codes checked before the claim is submitted.
  • Documentation review — staging detail reviewed against each payer's specificity requirements.

Accelerated Enrollment for Oncology Practices

Enrollment is the first line of defense for oncology revenue. We manage license renewal tracking, monthly OIG/SAM exclusion checks, and enrollment across the payers and specialty pharmacy networks most active in oncology — so your practice stays enrolled and compliant, and authorizations and claims are not interrupted by a lapsed renewal or an enrollment gap.

Because high-cost drug authorizations often require re-verification mid-treatment, we monitor authorization status throughout a patient's full treatment course, not just at intake.

  • License renewal tracking — renewals tracked so credentials stay current.
  • Monthly OIG/SAM exclusion checks — run every month to keep your practice compliant.
  • Enrollment across payers and specialty pharmacy networks — the networks most active in oncology.
  • Authorization monitoring — status monitored throughout the full treatment course, not just at intake.

Maintaining Compliance for Oncology Practices

Oncology billing requires precise, payer-specific handling — biosimilar substitution rules, prior authorization for high-cost specialty drugs, and staging specificity all vary by payer. Using the wrong biosimilar, or submitting staging documentation that is not specific enough, can trigger denials.

We track payer-specific biosimilar policies and review documentation against each payer's specificity requirements before submission, so compliance is built into every claim.

  • Payer-specific biosimilar policies — tracked to ensure correct submission.
  • ICD-10 staging specificity — documentation reviewed against payer specificity requirements.
  • NCCI edits on radiation therapy bundling — modifier verification before claim submission.
  • Mid-treatment re-verification — high-cost drug authorizations monitored throughout the treatment course.

Bolstering Revenue Integrity for Oncology Leaders

A single denied prior authorization on a six-figure treatment plan can devastate a practice's cash flow. We track these details so oncology practices don't absorb that risk — verifying authorization before treatment begins and monitoring status throughout the full treatment course.

Every claim is checked before submission: session-level coding, biosimilar policy, staging specificity, and radiation bundling — so denials are prevented, not chased.

  • Pre-treatment authorization verification — high-cost drug authorizations verified before treatment begins.
  • Session-level coding review — before submission, to catch sequencing errors.
  • Full-course authorization monitoring — status tracked throughout the patient's treatment.
  • Documentation review before submission — to prevent denials from insufficient staging detail.

Common Questions

Oncology Billing Credentialing — FAQ

How do you handle prior authorization for high-cost oncology drugs?

We verify authorization before treatment begins and monitor status throughout the full treatment course, since many high-cost drug authorizations require re-verification mid-treatment — a common point where practices lose revenue if not tracked proactively.

Do biosimilar substitution rules affect my billing?

Yes — payers have different rules on originator versus biosimilar billing, and using the wrong one can trigger denials. We track payer-specific biosimilar policies to ensure correct billing.

Why do my chemotherapy administration claims get denied?

The most common cause is incorrect sequencing when multiple drugs are administered in the same session under codes 96401–96549. We review session-level coding before submission to catch this.

How specific does my ICD-10 staging documentation need to be?

Payers increasingly require detailed staging specificity to approve oncology claims. We review documentation against each payer's specificity requirements before submission to prevent denials.

Explore More

Related Locations & Specialties

Protect Your Oncology Practice's Revenue From Authorization Gaps

Free Payer Performance Audit — no sales pitch, benchmarked against oncology billing standards.

Request Your Free Audit →

We're Here to Help

Support Your Practice with Expert Billing & Credentialing from Pro Health Care Advisors

Call us today for comprehensive practice support. We specialize in billing, resolving claim denials, authorizations, patient statements, RCM reporting, credentialing, collections, and offering a wide range of services to expand and enhance your practice.

Opening Hours
Mon–Fri: 8am – 6pm
Sat: Closed
Sun: Closed

Contact Us
(888) 341-4599